Mirko Compagno

Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study

Mario Tumbarello, Francesca Raffaelli, Maddalena Giannella et al. · Clinical Infectious Diseases · 2021 · 266 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +11

Latent tuberculosis infection screening in persons newly-diagnosed with HIV infection in Italy: A multicentre study promoted by the Italian Society of Infectious and Tropical Diseases

Delia Goletti, Assunta Navarra, Elisa Petruccioli et al. · International Journal of Infectious Diseases · 2019 · 19 citations · Full text

Public Health, Infectious Diseases, Preventive Medicine +17

In Patients with Severe COVID-19, the Profound Decrease in the Peripheral Blood T-Cell Subsets Is Correlated with an Increase of QuantiFERON-TB Gold Plus Indeterminate Rates and Reflecting a Reduced Interferon-Gamma Production

Alessandra Imeneo, Grazia Alessio, Andrea Di Lorenzo et al. · Life · 2022 · 15 citations · Full text

Medicine, Immunology, Infectious Diseases +11

Resistance to Ceftazidime/Avibactam in Klebsiella pneumoniae KPC-Producing Isolates: A Real-Life Observational Study

Laura Campogiani, Pietro Vitale, A Lodi et al. · Antibiotics · 2023 · 13 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study

Jessica Cusato, Alberto Borghetti, Elisabetta Teti et al. · Metabolites · 2022 · 12 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17